Lenrispodun

N/A

Report date: 2025/06/13 15:50:20
NME

Base Information

Drug NameLenrispodun
Drug Alias NameIC200214 phosphateITI200214-phosphateITI-12-Cyclo-(S,R) phosphateITI-214 phosphateITI12-phosphate +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 1 inhibitors
TargetsPhosphodiesterase 1
Therapy Area/IndicationsSchizophreniaHeart Failure, SystolicParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesIntra-Cellular Therapies Inc
China Registration ClassN/A

Develop Information

Active CompaniesIntra-Cellular Therapies Inc
Inactive CompaniesTakeda Pharmaceutical Co Ltd
Active IndicationsParkinson Disease
Inactive IndicationsSchizophreniaHeart Failure, Systolic

Other Information

ATC CodeN/A
Related LinksN/A